TIGENICHE (Tigecycline) is the first clinically-available drug in a new class of antibiotics called the glycylcyclines. Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Tigecycline injection is used to treat bacterial infections in many different parts of the body (eg, infections on the skin, stomach, or lungs). It works by killing bacteria or preventing their growth.

Therapy Area: Antibiotic (Injectable)
Form: Parentral intravenous injection
Packaging: 1x1 vial


Tigecycline 50mg


Tigecycline, a glycylcycline, inhibits protein translation in bacteria by binding to the 30S ribosomal subunit and blocking entry of amino-acyl tRNA molecules into the A site of the ribosome. This prevents incorporation of amino acid residues into elongating peptide chains.


  • Complicated intraabdominal infections (CIAI)
  • Community Acquired Pneumonia (CAP)
  • Skin and Skin Structure Infections
  • Ventilator-associated pneumonia (VAP)
  • MDR Acinetobacter infection


Adult (Initial) : 100mg as a single dose

Adult (Maintenances): 50 mg every 12 hours for 7 to 14 days

Children >12 years & adolescents : 50 mg every 12 hours


This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.

Enquire About TIGENICHE

Fill the form below and we will get in touch with you

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.